Vaccination Guidelines for Patients with Immune-Mediated Disorders on Immunosuppressive Therapies-Executive Summary. 

November 15, 2019 at 8:13 am

Journal of the Canadian Association of Gastroenterology  December 2019 V.2 N.4 P.149-152.

Papp KA, Haraoui B, Kumar D, Marshall JK, Bissonnette R, Bitton A, et al.

The use of immunosuppressive therapies for immune-mediated disease (IMD) is associated with an elevated risk of infections and related comorbidities. While many infectious diseases can generally be prevented by vaccines, immunization rates in this specific patient population remain suboptimal, due in part to uncertainty about their efficacy or safety under these clinical situations. To address this concern, a multidisciplinary group of Canadian physicians with expertise in dermatology, gastroenterology, infectious diseases and rheumatology developed evidence-based clinical guidelines on vaccinations featuring 13 statements that are aimed at reducing the risk of preventable infections in individuals exposed to immunosuppressive agents.

FULL TEXT

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785689/

PDF

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785689/pdf/gwy069.pdf

Entry filed under: CONSENSOS, Epidemiología, GUIDELINES, HIC no SIDA, Infecciones en esplenectomizados, Infecciones en neutropenicos, Infecciones en onco-hematologicos, Infecciones en transplantados, Inmunizaciones, Metodos diagnosticos, Prevencion y Control de Infecciones, REPORTS, Update.

Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Present and future of siderophore-based therapeutic and diagnostic approaches in infectious diseases.


Calendar

November 2019
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  

Most Recent Posts


%d bloggers like this: